By Professor Ric Day

Journal articles

Kino R; Day RO; Pearce GA; Fulde GWO, 1991, 'Aminophylline in the emergency department: Maximizing safety and efficacy', Chest, 100, pp. 1572 - 1577, http://dx.doi.org/10.1378/chest.100.6.1572

Kino R; Day RO; Pearce GA; Fulde GWO, 1991, 'Bedside measurement of plasma theophylline concentration within the emergency department', Australian Journal of Hospital Pharmacy, 21, pp. 292 - 294

Winn JS; Guille J; Gebicki JM; Day RO, 1991, 'Hydrogen peroxide modulation of the respiratory burst of human neutrophils', Biochemical Pharmacology, 41, pp. 31 - 36, http://dx.doi.org/10.1016/0006-2952(91)90007-R

Handel ML; DeFazio A; Watts CKW; Day RO; Sutherland RL, 1991, 'Inhibition of DNA binding and transcriptional activity of a nuclear receptor transcription factor by aurothiomalate and other metal ions', Molecular Pharmacology, 40, pp. 613 - 618

Day RO; Williams KM; Graham S; Handel M, 1991, 'The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma', Arthritis & Rheumatism, 34, pp. 751 - 760, http://dx.doi.org/10.1002/art.1780340617

Johnson AG; Day RO, 1991, 'The Problems and Pitfalls of NSAID Therapy in the Elderly (Part I)', Drugs & Aging, 1, pp. 130 - 143, http://dx.doi.org/10.2165/00002512-199101020-00005

Johnson AG; Day RO, 1991, 'The Problems and Pitfalls of NSAID Therapy in the Elderly (Part II)', Drugs & Aging, 1, pp. 212 - 227, http://dx.doi.org/10.2165/00002512-199101030-00005

Nuernberg B; Knihinicki R; Williams K; Freeman GE; Dalton C; Brooks PM; Day RO, 1990, 'Anti-inflammatory effects and disposition of S- and R-flurbiprofen in the rat', European Journal of Pharmacology, 183, pp. 1591 - 1592, http://dx.doi.org/10.1016/0014-2999(90)94757-O

Johnson AG; Day RO; Seldon WA, 1990, 'A functional psychosis precipitated by quinidine', Medical Journal of Australia, 153, pp. 47 - 49, http://dx.doi.org/10.5694/j.1326-5377.1990.tb125463.x

Tett S; Cutler D; Day R, 1990, 'Antimalarials in rheumatic diseases', Bailliere's Clinical Rheumatology, 4, pp. 467 - 489, http://dx.doi.org/10.1016/S0950-3579(05)80004-4

Pearce GA; Day RO, 1990, 'Compliance with criteria necessary for effective drug concentration monitoring', Therapeutic Drug Monitoring, 12, pp. 250 - 257, http://dx.doi.org/10.1097/00007691-199005000-00007

Joyce D; Day R, 1990, 'D‐penicillamine and D‐penicillamine‐protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.', British Journal of Clinical Pharmacology, 30, pp. 511 - 517, http://dx.doi.org/10.1111/j.1365-2125.1990.tb03808.x

Tett SE; Cutler DJ; Day RO, 1990, 'Hydroxychloroquine concentrations and clinical effects in rheumatoid arthritis patients', European Journal of Pharmacology, 183, pp. 1035, http://dx.doi.org/10.1016/0014-2999(90)92892-M

Knihinicki RD; Day RO; Graham GG; Williams KM, 1990, 'Stereoselective disposition of ibuprofen and flurbiprofen in rats', Chirality, 2, pp. 134 - 140, http://dx.doi.org/10.1002/chir.530020303

Knihinicki RD; Williams KM; Day RO, 1989, 'Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs-1. In vitro studies of ibuprofen and flurbiprofen', Biochemical Pharmacology, 38, pp. 4389 - 4395, http://dx.doi.org/10.1016/0006-2952(89)90647-3

Sambrook PN; Champion GD; Browne CD; Cairns D; Cohen ML; Day RO; Graham S; Handel M; Jaworski R; Kempler S; Wach er T, 1989, 'Corticosteroid injection for osteoarthritis of the knee: Peripatellar compared to intra-articular route', Clinical and Experimental Rheumatology, 7, pp. 609 - 613

Day R, 1989, 'Trends in the treatment of rheumatoid arthritis: Australia', Rheumatology SEAPAL 1988: proceedings of the 6th SEAPAL Congress of rheumatology. ICS809, pp. 159 - 161

Tett S; Cutler D; Day R; Brown K, 1989, 'Bioavailability of hydroxychloroquine tablets in healthy volunteers.', British Journal of Clinical Pharmacology, 27, pp. 771 - 779, http://dx.doi.org/10.1111/j.1365-2125.1989.tb03439.x

Graham SR; Day RO; Hardy M, 1989, 'Captopril overdose', Medical Journal of Australia, 151, pp. 111, http://dx.doi.org/10.5694/j.1326-5377.1989.tb101174.x

Day R; Graham G; Bieri D; Brown M; Cairns D; Harris G; Hounsell J; Platt‐ Hepworth S; Reeve R; Sambrook P; et al , 1989, 'Concentration‐response relationships for salicylate‐induced ototoxicity in normal volunteers.', British Journal of Clinical Pharmacology, 28, pp. 695 - 702, http://dx.doi.org/10.1111/j.1365-2125.1989.tb03562.x

HO KY; WEISSBERGER AJ; STUART MC; DAY RO; LAZARUS L, 1989, 'THE PHARMACOKINETICS, SAFETY AND ENDOCRINE EFFECTS OF AUTHENTIC BIOSYNTHETIC HUMAN GROWTH HORMONE IN NORMAL SUBJECTS', Clinical Endocrinology, 30, pp. 335 - 345, http://dx.doi.org/10.1111/j.1365-2265.1989.tb00431.x

Bowden GJ; Cadogan JM; Day RK; Dunlop JB, 1988, '¹⁶⁹Tm Mössbauer experiments in the paramagnetic phase of Tm2 Al', Hyperfine Interactions, 39, pp. 359 - 367, http://dx.doi.org/10.1007/BF02397645

Stewart GA; Day RK; Dunlop JB; Price DC, 1988, 'A two-site analysis of¹⁶⁹Tm Mössbauer measurements on thulium sesquioxide', Hyperfine Interactions, 40, pp. 339 - 342, http://dx.doi.org/10.1007/BF02049112

Patapanian H; Graham S; Sambrook PN; Browne CD; Champion GD; Cohen ML; Day RO, 1988, 'The oncogenicity of chlorambucil in rheumatoid arthritis', Rheumatology, 27, pp. 44 - 47, http://dx.doi.org/10.1093/rheumatology/27.1.44

Tett S; Cutler D; Day R; Brown K, 1988, 'A dose‐ranging study of the pharmacokinetics of hydroxy‐chloroquine following intravenous administration to healthy volunteers.', British Journal of Clinical Pharmacology, 26, pp. 303 - 313, http://dx.doi.org/10.1111/j.1365-2125.1988.tb05281.x

Day R; Miners J; Birkett D; Whitehead A; Naidoo D; Hayes J; Savdie E, 1988, 'Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.', British Journal of Clinical Pharmacology, 26, pp. 423 - 428, http://dx.doi.org/10.1111/j.1365-2125.1988.tb03401.x

Day RO; Breit SN; Cairns D; Champion GD, 1988, 'Aspects of the clinical trials of slow-acting anti-rheumatic drugs.', Agents and actions. Supplements, 24, pp. 121 - 133, http://dx.doi.org/10.1007/978-3-0348-9160-8_11

Day RO; Furst DE; Dromgoole SH; Paulus HE, 1988, 'Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteers', Biopharmaceutics & Drug Disposition, 9, pp. 273 - 283, http://dx.doi.org/10.1002/bod.2510090306

Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; De Jager J; Sambrook PN, 1988, 'Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis', Journal of Rheumatology, 15, pp. 28 - 34

Day R; Harris G; Brown M; Graham G; Champion G, 1988, 'Interaction of salicylate and corticosteroids in man.', British Journal of Clinical Pharmacology, 26, pp. 334 - 337, http://dx.doi.org/10.1111/j.1365-2125.1988.tb05286.x

Day RO, 1988, 'Mode of action of non-steroidal anti-inflammatory drugs', Medical Journal of Australia, 148, pp. 195 - 199, http://dx.doi.org/10.5694/j.1326-5377.1988.tb112818.x

Graham SR; Day RO; Lee R; Fulde GWO, 1988, 'Overdose with chloral hydrate: A pharmacological and therapeutic review', Medical Journal of Australia, 149, pp. 686 - 688, http://dx.doi.org/10.5694/j.1326-5377.1988.tb120823.x

Day RO; Graham GG; Williams KM, 1988, 'Pharmacokinetics of non-steroidal anti-inflammatory drugs', Bailliere's Clinical Rheumatology, 2, pp. 363 - 393, http://dx.doi.org/10.1016/S0950-3579(88)80019-0

Day R; Miners J; Birkett D; Graham G; Whitehead A, 1988, 'Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.', British Journal of Clinical Pharmacology, 26, pp. 429 - 434, http://dx.doi.org/10.1111/j.1365-2125.1988.tb03402.x

Day RO; Williams KM; Graham GG; Lee EJ; Knihinicki RD; Champion GD, 1988, 'Stereoselective disposition of ibuprofen enantiomers in synovial fluid', Clinical Pharmacology and Therapeutics, 43, pp. 480 - 487, http://dx.doi.org/10.1038/clpt.1988.62

Williams KM; Day RO, 1988, 'The contribution of enantiomers to variability in response to anti-inflammatory drugs.', Agents and actions. Supplements, 24, pp. 76 - 84, http://dx.doi.org/10.1007/978-3-0348-9160-8_7

Day R; Paull P; Lam S; Swanson B; Williams K; Wade D, 1988, 'The effect of concurrent aspirin upon plasma concentrations of tenoxicam.', British Journal of Clinical Pharmacology, 26, pp. 455 - 462, http://dx.doi.org/10.1111/j.1365-2125.1988.tb03405.x

Keogh A; Day R; Critchley L; Duggin G; Baron D, 1988, 'The effect of food and cholestyramine on the absorption of cyclosporine in cardiac transplant recipients', Transplantation Proceedings, 20, pp. 27 - 30

Day RO; Graham GG; Willia KM; Brooks PM, 1988, 'Variability in Response to NSAIDs: Fact or Fiction?', Drugs, 36, pp. 643 - 651, http://dx.doi.org/10.2165/00003495-198836060-00001

Reilly DK; Ray JE; Day RO; Wodak A; O'Connor D; Thompson J, 1987, 'Classification of overdose/self-poisoning presentations to an accident and emergency department', International Journal of the Addictions, 22, pp. 941 - 955

WING LMH; MOULDS RFW; SHENFIELD GM; DAY RO, 1987, 'DRUG ADVERTISING - REPLY', MEDICAL JOURNAL OF AUSTRALIA, 147, pp. 361 - 361, http://dx.doi.org/10.5694/j.1326-5377.1987.tb133532.x

MOULDS RFW; DAY RO, 1987, 'DRUG ADVERTISING', MEDICAL JOURNAL OF AUSTRALIA, 147, pp. 52 - 52, http://dx.doi.org/10.5694/j.1326-5377.1987.tb133252.x

PATAPANIAN H; SAMBROOK PN; BROWNE CD; CHAMPION GD; DAY RO; COHEN ML, 1987, 'ONCHOGENICITY OF CHLORAMBUCIL IN RHEUMATOID-ARTHRITIS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 17, pp. 124 - 124, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1987G353300058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mant A; Wodak A; Day R, 1987, 'Benzodiazepine dependence. Strategies for prevention and withdrawal', Current Therapeutics, 28, pp. 59 - 79

Reilly DK; Ray JE; Day RO; Wodak A; Bsocstud DOC; Thompson J, 1987, 'Classification of overdose/self-poisoning presentations to an accident and emergency department', Substance Use and Misuse, 22, pp. 941 - 955, http://dx.doi.org/10.3109/10826088709109691

Day RO; Graham GG; Williams KM; David Champion G; de Jager J, 1987, 'Clinical pharmacology of non-steroidal anti-inflammatory drugs', Pharmacology and Therapeutics, 33, pp. 383 - 433, http://dx.doi.org/10.1016/0163-7258(87)90072-6

Day R; Lam S; Paull P; Wade D, 1987, 'Effect of food and various antacids on the absorption of tenoxicam.', British Journal of Clinical Pharmacology, 24, pp. 323 - 328, http://dx.doi.org/10.1111/j.1365-2125.1987.tb03176.x

Day R; Brooks P, 1987, 'Variations in response to non‐steroidal anti‐inflammatory drugs.', British Journal of Clinical Pharmacology, 23, pp. 655 - 658, http://dx.doi.org/10.1111/j.1365-2125.1987.tb03098.x

Sambrook PN; Champion GD; Browne CD; Cohen ML; Compton P; Day RO; Jager JD, 1986, 'Comparison of methotrexate with azathioprine or 6-mercaptopurine in refractory rheumatoid arthritis: A life-table analysis', Rheumatology, 25, pp. 372 - 375, http://dx.doi.org/10.1093/rheumatology/25.4.372

Goadsby PJ; Day RO; Kwan YL; Miners J; Birkett DJ, 1986, '6-MERCAPTOPURINE-RELATED LEUCOPENIA AND IN VIVO XANTHINE OXIDASE ACTIVITY', The Lancet, 328, pp. 869 - 870, http://dx.doi.org/10.1016/S0140-6736(86)92911-9

Back to profile page